PET for radiation treatment planning of brain tumours.

Abstract	AA-PET (MET-PET and FET-PET) can be used for gross tumour volume (GTV) delineation in brain gliomas and for the differentiation between treatment-related changes (pseudo-progression, pseudo-regression) and residual/recurrent tumour. There are some data showing that MET-PET and (DOTATOC)-PET can be used for GTV delineation in meningiomas and glomus tumours. The role of PET in the visualization of the biological characteristics of the tumours: proliferation (FLT-PET), hypoxia (FMISO-PET) and angiogenesis/peptide expression (RGD-PET) should be investigated in future studies.
Authors	Anca-L Grosu, Wolfgang A Weber
Journal	Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology (Radiother Oncol) Vol. 96 Issue 3 Pg. 325-7 (Sep 2010) ISSN: 1879-0887 [Electronic] Ireland
PMID	20728952 (Publication Type: Journal Article, Review)
Copyright	Copyright 2010 European Society for Therapeutic Radiology and Oncology and European Association of Nuclear Medicine. Published by Elsevier Ireland Ltd.. All rights reserved.
Topics	Brain Neoplasms (diagnostic imaging, pathology, radiotherapy) Humans Positron-Emission Tomography (methods) Radiotherapy Planning, Computer-Assisted (methods)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!